Stock Ticker

  • Loading stock data...

Sanofi SA (NASDAQ:SNY) Would Focus On Cancer Treatments For Rapid Growth: Sanofi In Advanced Stage To Divest Seprafilm

Sanofi SA (NASDAQ:SNY) is in advanced talks to divest Seprafilm to Baxter International Inc (NYSE:BAX). Seprafilm is valued at up to $400 million. It is used to eliminate scars resulting from pelvic and abdominal surgeries. Sanofi intends to focus on cancer treatments to achieve rapid growth. Products to reduce complications Baxter is engaged in the […]

Baxter International Inc. (NYSE:BAX) Progresses Ahead With VIVIA Haemodialysis System

Boston, MA 06/09/2014 (wallstreetpr) – Baxter International Inc. (NYSE:BAX) progresses in the terms of safety by curtailing the amount of uremic toxins that are associated with the conventional VIVIA Haemodialysis. The above was concluded only after adequate results from two major studies were collected and proved to be supporting the analysis. In Europe, December 2013; […]

Baxter International Inc. (NYSE:BAX) Goes On To Be A Global Leader In Hemophilia A

Boston, MA 06/05/2014 (wallstreetpr) – Baxter International Inc. (NYSE:BAX) is a global leader in health care services. The company caters to the needs of the people through many of its subsidiaries. These subsidiaries are actively involved in developing, manufactured and marketing products that make the health of people better thus giving them a better life […]

Baxter International Inc. (NYSE:BAX) Identified As A Pre-Market Leader

Boston, MA 10/29/2013 (wallstreetpr) – Baxter International Inc. (NYSE:BAX) is primarily a health care company that specializes in treating hemophilia, immune disorders and trauma amongst others. It is involved in both drug development and manufacture. Trade-Ideas LLC is the analyst firm hat had identified Baxter International as a pre-market stock leader. The reason for categorizing this […]

Sign Up To Get Our Latest Stocks Alerts